Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
2011/07/25 by Jorge E. Osorio, Claire Y.-H. Huang, Claire Y.‐H. Huang +2 · 26 citations
Medicine · #Mosquito-borne diseases and control #Viral Infections and Vectors #Viral Infections and Outbreaks Research
paper · doi:10.1016/j.vaccine.2011.07.020
Citations
Cited by
- Dengue vaccine [wikipedia]
- Understanding the dengue viruses and progress towards their control. [europepmc]
- Dengue vaccines: recent developments, ongoing challenges and current candidates. [europepmc]
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study. [europepmc]
- Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice. [europepmc]
- Utility, limitations, and future of non-human primates for dengue research and vaccine development. [europepmc]
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial. [europepmc]
- The dengue vaccine pipeline: Implications for the future of dengue control. [europepmc]
- Immune correlates for dengue vaccine development. [europepmc]
- Tackling dengue fever: Current status and challenges. [europepmc]
- Molecular determinants of plaque size as an indicator of dengue virus attenuation. [europepmc]
- Vaccines licensed and in clinical trials for the prevention of dengue. [europepmc]
- Historical Perspectives on Flavivirus Research. [europepmc]
- The 5' and 3' Untranslated Regions of the Flaviviral Genome. [europepmc]
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner. [europepmc]
- Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties. [europepmc]
- Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies. [europepmc]
- Dengue: a growing threat requiring vaccine development for disease prevention. [europepmc]
- Recent advances in understanding dengue. [europepmc]
- Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial. [europepmc]
- Cross-Reactive Immunity Among Flaviviruses. [europepmc]
- Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. [europepmc]
- Dengue: A Minireview. [europepmc]
- A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice. [europepmc]
- Flavivirus NS1 and Its Potential in Vaccine Development. [europepmc]
- Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective. [europepmc]